These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 9817186

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms.
    Wolf G.
    Nephrologie; 1998; 19(7):451-6. PubMed ID: 9857383
    [Abstract] [Full Text] [Related]

  • 28. Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuria.
    Benigni A, Corna D, Zoja C, Longaretti L, Gagliardini E, Perico N, Coffman TM, Remuzzi G.
    J Am Soc Nephrol; 2004 Oct; 15(10):2666-74. PubMed ID: 15466271
    [Abstract] [Full Text] [Related]

  • 29. Endothelin receptors in the kidney of patients with proteinuric and non-proteinuric nephropathies.
    Drakopoulos A, Goumenos DS, Vlachojannis JG, Tsakas S.
    Ren Fail; 2006 Oct; 28(6):461-7. PubMed ID: 16928614
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Vasoactive factors and tubulointerstitial injury.
    Wolf G.
    Kidney Blood Press Res; 1999 Oct; 22(1-2):62-70. PubMed ID: 10352409
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Physiology and cell biology update: polypeptide growth factors and their relation to renal disease.
    Kujubu DA, Fine LG.
    Am J Kidney Dis; 1989 Jul; 14(1):61-73. PubMed ID: 2662764
    [Abstract] [Full Text] [Related]

  • 37. Experimental models of nephron reduction: some answers, many questions.
    Kleinknecht C, Terzi F, Burtin M, Laouari D, Maniar S.
    Kidney Int Suppl; 1995 Jun; 49():S51-4. PubMed ID: 7674595
    [No Abstract] [Full Text] [Related]

  • 38. Understanding the nature of renal disease progression.
    Remuzzi G, Ruggenenti P, Benigni A.
    Kidney Int; 1997 Jan; 51(1):2-15. PubMed ID: 8995712
    [Abstract] [Full Text] [Related]

  • 39. Is there hope for preventing or slowing the progression of chronic renal disease? More support for the role of growth factors.
    Crook ED.
    Am J Kidney Dis; 2001 Sep; 38(3):652-7. PubMed ID: 11532701
    [No Abstract] [Full Text] [Related]

  • 40. Interactions between growth factors in the kidney: implications for progressive renal injury.
    Cooper ME, Thomas MC.
    Kidney Int; 2003 Apr; 63(4):1584-5. PubMed ID: 12631379
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.